ATOS today
$2.03-$0.11 (-5.14%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns up above $6.28
Key levels
Resistance$2.61
Resistance$2.38
Support$1.98
Support$1.70
Latest news & SEC filings
EarningsAtossa Therapeutics Posts Q3 2026 Financial Results
EarningsAtossa Therapeutics posts smaller Q3 loss than expected
SEC FilingAtossa Therapeutics, Inc. filed a report on a major company event (Form 8-K)
All ATOS news →About Atossa Therapeutics
Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for breast cancer and other diseases. Its main program involves a proprietary form of a tamoxifen byproduct, which is being tested for breast cancer and Duchenne muscular dystrophy. The company operates in the United States and depends on outside suppliers and research organizations for its development and manufacturing work.
Based on the company's 10-K filed Mar 25, 2026.
Nasdaq · Healthcare
ATOSSA THERAPEUTICS, INC. (ATOS)
What Is the Price Target for ATOS?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is ATOS a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ATOS.
Start Free Trial →Is ATOS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$7.80
12
Moat Score
NONE
1/9
Piotroski Score
-7.6
Altman Z-Score
What Is Smart Money Doing with ATOS?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ATOS Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-32.89%
FCF Growth YoY
-41.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for ATOS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ATOS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:43:21 | $2.03 | 1,000 | $$2K | SELL |
| 20:57:06 | $2.05 | 5,000 | $$10K | BUY |
| 20:53:23 | $2.07 | 3,000 | $$6K | BUY |
| 20:52:29 | $2.06 | 5,000 | $$10K | BUY |
| 20:23:02 | $2.04 | 2,000 | $$4K | SELL |
5 dark pool trades shown · $$33K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ATOSSA THERAPEUTICS, INC. (ATOS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ATOS — frequently asked questions
What is ATOS stock price today?
ATOSSA THERAPEUTICS, INC. (ATOS) is at $2.03, down 5.14% (-$0.11) at the Nov 11, 2026 close.
Why is ATOS stock moving today?
Latest ATOS news — Nov 10, 2026: Atossa Therapeutics Posts Q3 2026 Financial Results · Nov 10, 2026: Atossa Therapeutics posts smaller Q3 loss than expected
What do analysts rate ATOS?
Analyst ratings for ATOS: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did ATOS beat earnings?
ATOS last reported on Aug 7, 2026: EPS -$0.95 vs -$1.02 expected — a beat of 6.9%.
Does ATOS pay a dividend?
ATOS does not currently pay a dividend.
What are ATOS support and resistance levels?
Support: $1.98, $1.70. Resistance: $2.38, $2.61, $2.85.
What are insiders doing with ATOS?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on ATOS?
Nov 10, 2026: Atossa Therapeutics Posts Q3 2026 Financial Results · Nov 10, 2026: Atossa Therapeutics posts smaller Q3 loss than expected · Nov 10, 2026: Atossa Therapeutics, Inc. filed a report on a major company event (Form 8-K)